| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |